CTDA | SingHealth Duke-NUS

A prestigious award that provides protected time for 2 years (0.2 FTE for Clinical Trialist; 0.4 FTE for Master Clinical Trialist), with the aim to develop clinicians with expertise and interest in the conduct of clinical trials.

The CTDA promotes recognition for the pursuit of clinical research and demonstrates institutional and national prestige. It supports the endeavours of Clinical Trialists at varying levels to deepen focus on research efforts through clinical trials and ensure quality care and patient safety.

Application is closed for 2025.

For more information, look out for the next Call for Applications in early 2026.

Infosheet

1. Clinical Trialist Development Award_Infosheet

Eligibility & Evaluation Criteria

Each submission must be made using the prescribed forms:

Clinical Trialist Development Award Application Form (to be completed by applicant)
Applicant CV & Career Development Plan (to be completed by applicant)
Nomination Form (to be completed and endorsed by Clinical HOD, ACP Chair and SDDC Head (where applicable)).

Please click here for more information and application materials.

For submission of applications or any enquiries, please contact Ms Regina Koh at regina.koh@duke-nus.com.sg.

Applications that fail to comply with requirements in any of the templates and/or incomplete applications will be disqualified and will not be reviewed.

Proposals should define clear and measurable deliverables / outcomes.
The criteria of the applicant and the expected outcomes are as follow:

	Clinical Trialist	Master Clinical Trialist
Criteria	A Clinician who: Is a PI of 2 or more Clinical Trials in the past 2 years; Secured trial contract value of >S$500,000 over a 2-year period and Achieved average recruitment target of ≥50% for all the trials in the past 2 years OR Is overall Chief PI of Investigator Initiated Clinical Trial who has designed the trial and secured funding for the trial with contract value of >S$500,000	A Clinician who: Is a PI of 5 or more Clinical Trials in the past 2 years;　 Secured trial contract value of >S$1 million over a 2-year period and Achieved recruitment target of ≥50% for all the trials in the past 2 years OR Is overall Chief PI of Investigator Initiated Clinical Trial who has designed the trial and secured funding for the trial with contract value of >S$1 million
Protected Time	0.2 FTE per individual, to be reviewed every 2 years	0.4 FTE per individual, to be reviewed every 2 years
KPIs	New trials, recruitment target, actualised budget, compliance, training of junior investigators	New trials and grants, recruitment target, actualised budget, compliance, mentorship and training of junior investigators, publications, guideline / policy impact